Clinical Trial Update: Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating 0.25% timolol gel for improving healing and cosmetic outcomes after full thickness skin grafts; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Full Thickness Skin Graft Healing
• Surgical Wound

Drugs mentioned

• 0.25% Timolol Gel (timolol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Wound of Skin, Wound Heal | Phase 2, Phase 3 | Status: TERMINATED